137 related articles for article (PubMed ID: 16170854)
1. Spectral assignments for the aldose reductase inhibitor 4(S)-2,3-dihydro-6-fluoro-2(R)-methylspiro[chroman-4,4'-imidazoline]-2',5'-dione and its synthetic intermediates.
Wang M; Mishra MK; Zhu W; Kador PF
Magn Reson Chem; 2005 Dec; 43(12):1008-11. PubMed ID: 16170854
[TBL] [Abstract][Full Text] [Related]
2. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
El-Kabbani O; Darmanin C; Oka M; Schulze-Briese C; Tomizaki T; Hazemann I; Mitschler A; Podjarny A
J Med Chem; 2004 Aug; 47(18):4530-7. PubMed ID: 15317464
[TBL] [Abstract][Full Text] [Related]
3. 1H, 13C and 15N NMR spectral characterization of twenty-seven 1,2-diaryl-(4E)-arylidene-2-imidazolin-5-ones.
Laihia K; Kolehmainen E; Nikiforov V; Miltsov S
Magn Reson Chem; 2006 Sep; 44(9):895-900. PubMed ID: 16791910
[TBL] [Abstract][Full Text] [Related]
4. Assignments of 1H and 13C NMR spectral data for ondansetron and its two novel metabolites, 1-hydroxy-ondansetron diastereoisomers.
Duan M; Huang H; Li X; Chen X; Zhong D
Magn Reson Chem; 2006 Oct; 44(10):972-5. PubMed ID: 16835896
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
[TBL] [Abstract][Full Text] [Related]
6. 1H and 13C chemical shifts for some tetrasubstituted 2,5-diaryl di- and tetrahydrofuran derivatives.
Martinet S; Méou A; Brun P
Magn Reson Chem; 2007 Feb; 45(2):182-4. PubMed ID: 17154331
[TBL] [Abstract][Full Text] [Related]
7. Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitors.
Lipinski CA; Aldinger CE; Beyer TA; Bordner J; Burdi DF; Bussolotti DL; Inskeep PB; Siegel TW
J Med Chem; 1992 Jun; 35(12):2169-77. PubMed ID: 1613744
[TBL] [Abstract][Full Text] [Related]
8. A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography.
Oka M; Matsumoto Y; Sugiyama S; Tsuruta N; Matsushima M
J Med Chem; 2000 Jun; 43(12):2479-83. PubMed ID: 10882376
[TBL] [Abstract][Full Text] [Related]
9. [Imidazolidine/thiazolidine-acetate aldose reductase inhibitors].
Fresneau P
Ann Pharm Fr; 2000 Dec; 58(6):392-404. PubMed ID: 11148374
[TBL] [Abstract][Full Text] [Related]
10. 1H and 13C NMR spectral characterization of some novel 7H-1,2,4-triazolo[3, 4-b] [1,3,4] thiadiazine derivatives.
Lei X; Zhang L; Zhang A; Ye X; Xiong J
Magn Reson Chem; 2007 Mar; 45(3):265-8. PubMed ID: 17187343
[TBL] [Abstract][Full Text] [Related]
11. Complete assignments of 1H and 13C NMR spectra of leucanthoside A, a new triterpenoid saponin from Cephalaria leucantha L.
Godevac D; Mandić B; Vajs V; Menković N; Macura S; Milosavljević S
Magn Reson Chem; 2006 Jul; 44(7):731-5. PubMed ID: 16645935
[TBL] [Abstract][Full Text] [Related]
12. Protein structure-based de novo design and synthesis of aldose reductase inhibitors.
Iwata Y; Naito S; Itai A; Miyamoto S
Drug Des Discov; 2001; 17(4):349-59. PubMed ID: 11765138
[TBL] [Abstract][Full Text] [Related]
13. Structures and aldose reductase inhibitory effects of bromophenols from the red alga Symphyocladia latiuscula.
Wang W; Okada Y; Shi H; Wang Y; Okuyama T
J Nat Prod; 2005 Apr; 68(4):620-2. PubMed ID: 15844965
[TBL] [Abstract][Full Text] [Related]
14. Curcumin analogs as potent aldose reductase inhibitors.
Du ZY; Bao YD; Liu Z; Qiao W; Ma L; Huang ZS; Gu LQ; Chan AS
Arch Pharm (Weinheim); 2006 Mar; 339(3):123-8. PubMed ID: 16528793
[TBL] [Abstract][Full Text] [Related]
15. Unambiguous structural characterization of hydantoin reaction products using 2D HMBC NMR spectroscopy.
Senior MM; Chan TM; Li G; Huang Y; Stamford A
Magn Reson Chem; 2007 Mar; 45(3):240-4. PubMed ID: 17278178
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and NMR spectral studies of some 2,6-diarylpiperidin-4-one O-benzyloximes.
Parthiban P; Balasubramanian S; Aridoss G; Kabilan S
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):11-24. PubMed ID: 17889592
[TBL] [Abstract][Full Text] [Related]
17. 1H and 13C NMR spectral assignments of pyridinium salts linked to a N-9 or N-3 adenine moiety.
Rubio-Ruiz B; Conejo-García A; Gallo MA; Espinosa A; Entrena A
Magn Reson Chem; 2012 Jun; 50(6):466-9. PubMed ID: 22528078
[TBL] [Abstract][Full Text] [Related]
18. 1H and 13C NMR assignments for four triterpenoid saponins from Albizziae cortex.
Han LF; Ma BP; Zhang HS; Song XB; Gao XM; Kang LP; Xiong CQ; Zhao Y; Tan DW
Magn Reson Chem; 2008 Nov; 46(11):1059-65. PubMed ID: 18759334
[TBL] [Abstract][Full Text] [Related]
19. Unusual binding mode of the 2S4R stereoisomer of the potent aldose reductase cyclic imide inhibitor fidarestat (2S4S) in the 15 K crystal structure of the ternary complex refined at 0.78 A resolution: implications for the inhibition mechanism.
Zhao HT; Hazemann I; Mitschler A; Carbone V; Joachimiak A; Ginell S; Podjarny A; El-Kabbani O
J Med Chem; 2008 Mar; 51(5):1478-81. PubMed ID: 18284183
[TBL] [Abstract][Full Text] [Related]
20. New aldose reductase inhibitors N99-596 A and B from Streptomyces.
Dong Y; Yang J; Ren X; Zhang H; He J
J Antibiot (Tokyo); 2005 Nov; 58(11):737-9. PubMed ID: 16466028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
